Putting Patients First
Learn more about how we are working to discover and develop innovative medicines that are more accessible and affordable to patients around the world.
We are advancing an innovative, high-value product portfolio for patients globally.
Passion with Purpose
We work to benefit patients wherever they live by uniting worldwide talent and resources with our vision.
Our Commitment to Patients
We offer resources to help patients and their loved ones navigate some of the complex challenges that follow the words, “You have cancer.”
January 23, 2024
BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of DirectorsRead more
December 22, 2023
FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)Read more
November 29, 2023
BeiGene to Host ASH Investor Meeting in Person and via Webcast on December 10, 2023Read more
November 28, 2023